CANCER RESEARCH CAREER ENHANCEMENT (CRCE) The Fred Hutch/University of Washington Cancer Consortium aims to be at the forefront of training the next generation of scientists and clinicians to best position them to lead efforts to eliminate cancer. Education and training has always been a core value and central to our mission, and we propose here to continue to emphasize and enhance our training mission and footprint.
The specific aims for CRCE are (1) to provide exceptional training and support for graduate students and postdoctoral and clinical fellows so that they will be poised to tackle a range of careers in cancer research; (2) to encourage young students to engage in and experience science and to provide exposure and opportunities for those from groups that are underrepresented minorities (URMs) in science; (3) to maximize the success of junior faculty through mentoring and support as they transition to independent scientists; and (4) to support the pipeline of educational and training opportunities of the Consortium. To support our training efforts, we host a large and comprehensive set of T32 grants (n=47), of which 32 have Consortium faculty as mentors, 17 are led by Consortium PIs, and 7 are from NCI. The eight T32s with the strongest cancer focus collectively support 39 trainees/year, and an additional 95 trainees are supported by T32s that include cancer research as a component. Some of these grants have been in continuous existence for more than 4 decades (e.g., Molecular & Cellular Biology, Medical Scientist Training Program, Medical Genetics, Hematology). The caliber of our trainees and their success is illustrated by current active awards of 1 K99 grant, 6 K01 or K22 grants, 10 F32 grants, 2 Jane Coffin Childs Fellowships, 4 Damon Runyon Cancer Research Awards, and 4 Susan G. Komen Fellowships. This Cancer Research Career Enhancement (CRCE) component will serve as a centralized resource that integrates and supports these efforts, encourages the continuum of training and mentoring, and supports continued innovation in our education pipeline.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA015704-45
Application #
9853646
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-01-01
Budget End
2020-12-31
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Herman, Daniel S; Smith, Christina; Liu, Chang et al. (2018) Efficient Detection of Copy Number Mutations in PMS2 Exons with a Close Homolog. J Mol Diagn 20:512-521
Birnbaum, Jeanette K; Duggan, Catherine; Anderson, Benjamin O et al. (2018) Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modelling study. Lancet Glob Health 6:e885-e893
Partridge, Emma K; Neuhouser, Marian L; Breymeyer, Kara et al. (2018) Comparison of Nutrient Estimates Based on Food Volume versus Weight: Implications for Dietary Assessment Methods. Nutrients 10:
Jia, Deshui; Augert, Arnaud; Kim, Dong-Wook et al. (2018) Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition. Cancer Discov 8:1422-1437
Kuzma, Jessica N; Cromer, Gail; Hagman, Derek K et al. (2018) Consuming glucose-sweetened, not fructose-sweetened, beverages increases fasting insulin in healthy humans. Eur J Clin Nutr :
Neumeyer, Sonja; Banbury, Barbara L; Arndt, Volker et al. (2018) Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer 118:1639-1647
Puré, Ellen; Hingorani, Sunil R (2018) Mesenchymal Cell Plasticity and Perfidy in Epithelial Malignancy. Trends Cancer 4:273-277
Yu, Hsiang; Cheng, Yu-Jen; Wang, Ching-Yun (2018) Methods for multivariate recurrent event data with measurement error and informative censoring. Biometrics 74:966-976
Linden, Hannah M; Peterson, Lanell M; Fowler, Amy M (2018) Clinical Potential of Estrogen and Progesterone Receptor Imaging. PET Clin 13:415-422
Barault, Ludovic; Amatu, Alessio; Siravegna, Giulia et al. (2018) Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. Gut 67:1995-2005

Showing the most recent 10 out of 1267 publications